Mutual of America Capital Management LLC Has $4.03 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Mutual of America Capital Management LLC lessened its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 4.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 230,240 shares of the real estate investment trust’s stock after selling 11,299 shares during the period. Mutual of America Capital Management LLC’s holdings in Healthpeak Properties were worth $4,032,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Chevy Chase Trust Holdings LLC lifted its position in shares of Healthpeak Properties by 0.3% in the second quarter. Chevy Chase Trust Holdings LLC now owns 367,862 shares of the real estate investment trust’s stock worth $6,441,000 after buying an additional 973 shares during the last quarter. Arista Wealth Management LLC acquired a new stake in shares of Healthpeak Properties in the second quarter worth about $287,000. Stratos Wealth Advisors LLC acquired a new stake in Healthpeak Properties in the 2nd quarter worth approximately $182,000. Nordea Investment Management AB boosted its position in Healthpeak Properties by 7,444.0% during the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after purchasing an additional 3,871,201 shares during the period. Finally, Praxis Investment Management Inc. grew its holdings in Healthpeak Properties by 50.7% during the second quarter. Praxis Investment Management Inc. now owns 25,800 shares of the real estate investment trust’s stock valued at $452,000 after purchasing an additional 8,680 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

NYSE:DOC opened at $18.60 on Thursday. The company has a fifty day moving average price of $18.26 and a 200 day moving average price of $17.90. The stock has a market cap of $12.92 billion, a P/E ratio of 77.48, a PEG ratio of 3.17 and a beta of 1.09. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm’s revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.45 earnings per share. Analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.6%. Healthpeak Properties’s dividend payout ratio is 508.33%.

Analysts Set New Price Targets

DOC has been the topic of several analyst reports. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the company an “outperform” rating in a report on Wednesday, July 30th. Cantor Fitzgerald began coverage on shares of Healthpeak Properties in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Finally, Morgan Stanley cut their price objective on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday, August 22nd. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $21.33.

Insider Buying and Selling

In other news, CEO Scott M. Brinker purchased 2,930 shares of the business’s stock in a transaction on Thursday, July 31st. The stock was purchased at an average price of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer directly owned 210,416 shares in the company, valued at approximately $3,589,696.96. The trade was a 1.41% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Over the last ninety days, insiders purchased 8,783 shares of company stock valued at $150,129. Corporate insiders own 0.23% of the company’s stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.